🟢 Nasus Pharma is trading 8.17% up today with no identified company-specific catalyst

Nasus Pharma is trading at $3.31, up 8.17%, with no identified company-specific announcement explaining its October 22, 2026 move.

• The latest company news located was the September 29 update on its NS003 Phase 1 trial, not a new catalyst for this session.
• Healthcare shares are up 1.35%, which may offer supportive sector context; the broader market is lower, so the reason for the stock’s rise remains uncertain.